Dr Batra’s Introduces XODerma, India’s First Non-Injectable Exosome-Based Skin Rejuvenation Treatment
In a significant advancement in aesthetic dermatology, Dr Batra’s has launched XODerma, India’s first non-injectable, exosome-based skin rejuvenation treatment, marking a new chapter in anti-ageing and anti-pigmentation care. The treatment uniquely combines advanced exosome science with personalised homeopathy, offering a safe, painless and non-invasive solution for people seeking visible skin transformation without needles or downtime.
Designed to deliver noticeable results in just three sessions, Dr Batra’s® XODerma targets common concerns such as pigmentation, uneven skin tone, fine lines, loss of firmness and dull texture. Unlike conventional cosmetic procedures that work superficially, XODerma functions at a deep cellular level, promoting long-lasting skin repair and regeneration.
At the core of XODerma is exosome technology—nano-sized biological messengers that penetrate deeper layers of the skin to activate natural healing processes. These exosomes stimulate collagen production, improve cellular communication and support skin renewal, leading to progressive improvements in texture, tone, clarity and firmness over time.
Commenting on the launch, Dr Akshay Batra, Trichologist, Fellow in Homeopathic Cosmetology & Aesthetics and Managing Director, Dr Batra’s® Healthcare, said,
“After the successful introduction of exosome-based hair treatments in India, we are proud to bring XODerma to our patients. Today’s lifestyle—marked by pollution, stress and accelerated ageing—demands solutions that are effective yet safe. XODerma offers visible improvements in skin texture, tone and firmness within three sessions, while staying true to our commitment to natural, side-effect–free care.”
What sets XODerma apart is its integrative, dual-action approach. While exosomes work externally to repair and rejuvenate the skin, personalised homeopathic medicines address internal triggers such as hormonal imbalances, nutritional deficiencies, stress and lifestyle-related factors that contribute to pigmentation and premature ageing. This holistic strategy ensures more sustainable and balanced results.
The treatment is further strengthened by a blend of clinically supported skin actives, including peptides to smooth fine lines, hyaluronic acid for deep hydration and plumping, PDRN to stimulate collagen and DNA repair, and adenosine to accelerate skin renewal. Together, these ingredients enhance radiance, reduce pigmentation and refine overall skin quality.
Each XODerma session begins with an AI-powered skin analysis, assessing parameters such as pigmentation, pore size, hydration, texture and fine lines. Based on this data, doctors design a customised treatment plan. The procedure includes deep cleansing followed by micro-channel creation using a derma pen, allowing precise, non-injectable delivery of exosomes and actives into the skin—ensuring optimal absorption while maintaining comfort and safety.
Upon completion of the treatment cycle, patients receive an AI-generated outcome report, offering a transparent before-and-after comparison. The report highlights measurable improvements in pigmentation, skin tone, firmness and texture, providing scientific validation of results.
With the launch of XODerma, Dr Batra’s® continues to strengthen its position at the intersection of innovation and holistic care, offering patients a next-generation solution for healthier, youthful and radiant skin.
Be first to post your comments